Cornea/External disease CME

Welcome, Guest

OSN SuperSite Home

Upcoming Live Events

CME Activities

Show: All Journal Monograph Multimedia

Cornea/External disease


	Advanced Therapeutic Management of Ocular Surface Disease
	Author(s)/Faculty: Richard L. Lindstrom, MD; Eric D. Donnenfeld, MD; Edward J. Holland, MD; John D. more Sheppard, MD, MMSc
	Source: OCULAR SURGERY NEWS U.S. EDITION	Type: Monograph	Number of Articles: 5
	Release Date: June 2009	Expiration Date: June 25, 2010	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 1.00	Provider:
	OVERVIEW Ocular surface disease encompasses ocular allergy, blepharitis, and dry eye. As many as 30% of patients encountered by ophthalmologists have one of these conditions, yet an incorrect diagnosis is made approximately 50% of the time. This monograph will review the pathophysiology and clinical manifestations of each of these conditions. Therapeutic options for all aspects of ocular surface disease will be discussed, as well as clinical trials examining the efficacy and safety of these treatments. Lastly, advice on the appropriate management of the ocular surface in the surgical setting will be given.


	Ocular Pathogen Resistance: Emerging Clinical Data
	Author(s)/Faculty: Marguerite B. McDonald, MD, FACS; Richard L. Abbott, MD; Gary N. Foulks, MD, FACS; more Charles B. Slonim, MD, FACS
	Source: OCULAR SURGERY NEWS U.S. EDITION	Type: Monograph	Number of Articles: 5
	Release Date: June 2009	Expiration Date: June 10, 2010	Cost: $0.00 / $0.00
	Credit Type: CME	Number of Credit(s): 1.00	Provider:
	OVERVIEW The resistance of ocular pathogens to antibiotics continues to evolve and increase. Notably, resistance to newer generation fluoroquinolones has been shown to develop. This was surprising since they target 2 enzymes, as opposed to the older generation fluoroquinolones, which only have one target. This monograph will review the mechanisms by which bacteria may develop resistance, as well as the resistance patterns of various organisms to various antibiotics. Advice will be given on the proper usage of antibiotics, which can decrease the probability of the development of resistance. New agents on the horizon and clinical trials demonstrating their efficacy and safety will be discussed.